Bacterial wall chemical injected into tumors shows promise in early safety trial

NCT ID NCT05751837

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tested whether a sterile bacterial chemical called lipopolysaccharide (LPS) can be safely injected into abdominal tumors during laparoscopic surgery. Twelve adults with advanced digestive tract tumors received one injection into a tumor, and researchers checked for side effects and immune changes. The goal was to see if the treatment is safe and can activate the immune system against the cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Lipopolysaccharide (LPS), a bacterial wall chemical
What this could lead to
If safe, this could point toward a new way to stimulate the immune system to fight abdominal tumors during surgery.
What could go wrong
This is a very early Phase 1 trial with only 12 people, focused on safety, not effectiveness. The treatment may not shrink tumors or improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allegheny Health Network Allegheny General Hospital

    Pittsburgh, Pennsylvania, 15212, United States

  • Allegheny Health Network West Penn Hospital

    Pittsburgh, Pennsylvania, 15224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.